You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Idelalisib for treating chronic lymphocytic leukaemia

  • Technology appraisal guidance
  • Reference number: TA359
  • Published:  28 October 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Leukaemia (chronic lymphocytic, previously treated) - idelalisib [ID764]: final appraisal determination document

Leukaemia (chronic lymphocytic, previously treated) - idelalisib [ID764]: final appraisal determination document Leukaemia (chronic lymphocytic, previously treated) - idelalisib [ID764]: final appraisal determination document
24 September 2015
(452.58 Kb 11 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 22 September 2015

Back to top